tumor ReceivesAction determined by fda-approved test
Typicality: 0.429
Saliency: 0.420

Facets 2
with disease progression 7 other
after platinum-containing chemotherapy 6 temporal
Open triples 2
tumor → be determined by → fda-approved test 27
tumor → be detected by → fda-approved test 13
Sentiment analysis
negative neutral positive
0.089 0.797 0.114
Other statistics
Raw frequency 40
Normalized frequency 0.420
Modifier score 0.500
Perplexity 110.898